A specialty-based community offering psychiatric CME/CE courses, resources, and news, centered on you.
Psychology Advisor Institute Spotlight Course
Addressing Nutritional Deficiencies in Children with ADHD
1.00 CME CE: Reviews data supporting EFA supplementation in pediatric ADHD and distinctions between dietary supplements and medical foods. Exp 11/7/23
Additional Psychiatry Courses
A Novel Approach to Schizophrenia Treatment: What You Need to Know About TAAR1 Agonists
1.0 CME CE: Addressing unmet needs in schizophrenia. TAAR1 agonists are currently in development and may soon give patients a new treatment option. Exp 1/17/24
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
1.00 CME CE: Experts discuss new and emerging data on schizophrenia treatment, with a forward-looking view of new and novel agents. Exp 6/23/24
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
1.00 CME CE: Expert faculty focus on pathophysiology and current and emerging therapeutic strategies for the management of patients with schizophrenia. Exp 6/23/24
Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients With Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment
1.50 CME CE: A patient and caregiver share living with schizophrenia, with a focus on the difficulty of diagnosis and importance of communication. Exp 6/23/24
Agitation in Bipolar Disorder and Schizophrenia: Emergency Department Considerations
0.50 CME: Consider efficacy and safety of therapies as well as the safety of patient and staff. Exp 4/25/24
Tricky Business: Rethinking Our Approach to Tackling Schizophrenia
1.00 CME CE: Expert faculty will utilize animated 3-D models to discuss pathophysiology, negative symptomology, and CIAS in schizophrenia. Exp. 8/7/24
Addressing Nutritional Deficiencies in Children with ADHD
1.00 CME CE: Reviews data supporting EFA supplementation in pediatric ADHD and distinctions between dietary supplements and medical foods. Exp 11/7/23
The Latest Update on Metachromatic Leukodystrophy: Screening, Diagnosis, and Emerging Treatments to Improve Quality of Life of Patients
1.50 CME CE: Panelists discuss biomarkers that identify patients at the pre-symptomatic phase of metachromatic leukodystrophy. Exp. 12/6/23
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology
0.50 CME/CNE/CE: Key clues to the presence of early cognitive impairment due to Alzheimer’s Disease and best practices for its evaluation in primary care. Exp 2/28/24
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease
0.75 CME/CNE/CE: Key clues to the presence of early cognitive impairment due to Alzheimer’s Disease and best practices for its evaluation in primary care. Exp 2/28/24
Parkinson’s Disease Psychosis: Review of Neuropsychiatric Complications
1.00 CME: Parkinson’s disease psychosis (PDP) is a nonmotor symptom and manifests in an average of 35% of patients diagnosed with PD. Exp 3/9/24
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
1.00 CME CE: Experts discuss treatment and management of Parkinson disease psychosis, focusing on current and emerging therapeutic strategies. Exp 6/12/24
